Page last updated: 2024-08-25

rebeccamycin and Triple Negative Breast Neoplasms

rebeccamycin has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Deng, B; Liang, Z; Lu, X; Lu, Z; Shi, J; Sun, X; Zhu, Y	1

Other Studies

1 other study(ies) available for rebeccamycin and Triple Negative Breast Neoplasms

Article	Year
Transcriptomics and Proteomics Characterizing the Anticancer Mechanisms of Natural Rebeccamycin Analog Loonamycin in Breast Cancer Cells. Molecules (Basel, Switzerland), 2022, Oct-17, Volume: 27, Issue:20 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; ErbB Receptors; Humans; Mice; Phosphatidylinositol 3-Kinases; Proteomics; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Transcriptome; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53	2022

Article

Year

Transcriptomics and Proteomics Characterizing the Anticancer Mechanisms of Natural Rebeccamycin Analog Loonamycin in Breast Cancer Cells.

Molecules (Basel, Switzerland), 2022, Oct-17, Volume: 27, Issue:20

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; ErbB Receptors; Humans; Mice; Phosphatidylinositol 3-Kinases; Proteomics; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Transcriptome; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2022